C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
12/2001
12/06/2001	DE10012825A1 Verfahren zur Herstellung von spirocyclischen Tetronsäurederivaten Process for the preparation of spirocyclic Tetronsäurederivaten
12/06/2001	CA2599562A1 Compounds for modulating the rage receptor
12/06/2001	CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents
12/05/2001	EP1160245A1 Process for producing carbonyl compounds by dehydrogenation of alcohols
12/05/2001	EP1159278A2 Inhibitors of aspartyl protease
12/05/2001	EP1159276A2 Benzofuran-2-ones as colorants for organic materials
12/05/2001	EP1159274A2 Method for the preparation of citalopram
12/05/2001	EP1159265A1 C-16 unsaturated fp-selective prostaglandins analogs
12/05/2001	EP1159264A2 INHIBITORS OF FACTOR Xa
12/05/2001	EP1159261A2 Antizyme modulators and their use
12/05/2001	EP1158985A1 OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
12/05/2001	EP1053231B1 Process for the production of gamma-butyrolactone
12/05/2001	EP0828724B1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
12/05/2001	EP0779886B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
12/05/2001	EP0745075B1 6-substituted mycophenolic and derivatives with immunosuppressive activity
12/05/2001	EP0745071B1 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity
12/05/2001	EP0636026B1 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
12/05/2001	CN1325365A Polymetal oxide containing silver oxide and vanadium oxide and the use thereof
12/05/2001	CN1324794A Prepn. of diphenyl ether tetraformic dianhydride
12/05/2001	CN1324793A Prepn. of monochloro phthalic anhydride
12/05/2001	CN1324785A Organic matter recovering and halogen acid refining process of industrial acid effluent
12/04/2001	US6326395 Amidine or amide substituted furan derivatives
12/04/2001	US6326375 Containing an urea group
11/2001
11/29/2001	WO2001091223A1 Nonaqueous electrolytic solution and secondary battery containing the same
11/29/2001	WO2001090100A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	WO2001090097A2 Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
11/29/2001	WO2001090096A2 Triterpenoid derivatives and their use as antiproliferative agents
11/29/2001	WO2001090051A1 Phenylglycine derivatives
11/29/2001	WO2001089526A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
11/29/2001	WO2001060810B1 Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity
11/29/2001	WO2001055115A8 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/29/2001	WO2001029018A3 Novel enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
11/29/2001	WO2000034258A3 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
11/29/2001	CA2412651A1 Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
11/29/2001	CA2410294A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	CA2408791A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
11/28/2001	EP1157003A1 Acylated aminoacetonitriles as cysteine protease inhibitors
11/28/2001	EP0912089B1 Novel n-acyl sulphonamides, novel mixtures of herbicides and antidotes and their use
11/28/2001	EP0777674B1 Polynucleotide reagents having nonnucleotidic moieties, and associated methods of synthesis and use
11/28/2001	CN1324356A Process for preparing 3-(substituted phenyl)-5-thienyl or fully)-1,2,4-triazoles and nove. intermediates utilized therein
11/28/2001	CN1324351A Method for the preparation of citalopram
11/28/2001	CN1323794A Novel hetero naphthenic benzcyclobutane and heterocyclo acryl benzcyclobutane compound, their prepn. method and pharmaceutical composites
11/28/2001	CN1323793A Schizonepeta lactone and its extraction process and use
11/28/2001	CN1075496C Process for preparing 2-benzo-[c]-furanone
11/28/2001	CN1075495C Process for prepn. 2-(omega-alkoxycarbonylalkanoyl)-4-butanolide and long-chain omega-hydroxy carboxylic acid
11/28/2001	CN1075481C Process for refining high-purity reagent by raction extractive reactification
11/27/2001	US6323348 Process for producing cycloalkyl [b]benzofurans
11/27/2001	US6323347 Used for dehydrocyclization reaction of a diol under a gas phase to form lactone; activity, long lifetime and high selectivity of products
11/27/2001	US6323267 Isoxindigos useful as colorants and preparation thereof
11/27/2001	US6323235 Benzene-condensed heterocyclic derivatives and their uses
11/27/2001	US6323223 Ccr-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
11/27/2001	US6323207 Treatment or reduction of tissue damage due to ischaemia which comprises administering to a host suffering from ischaemia
11/27/2001	US6323199 Aromatic heterocyclic hydroxy amines or amides for treatment of inflammation
11/27/2001	US6323196 Galanthamine derivatives as acetylcholinesterase inhibitors
11/27/2001	US6323195 Enzyme inhibitors and cognition activators
11/27/2001	CA2041835C Cyclohexenone oxime ethers, their preparation and their use as herbicides
11/27/2001	CA2018562C Process for the enzymatic cleavage of vinyl 2-aryl-propionates
11/23/2001	CA2348301A1 Use of alpha-keto enamine derivatives as ingredients
11/22/2001	WO2001087870A1 Hydroxamic acid derivatives
11/22/2001	WO2001087869A1 A pharmaceutical composition containing the extract of saururus chinensis baill useful as and anticancer agent and a process for the preparation thereof
11/22/2001	WO2001087866A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	WO2001087830A2 Substituted thioacetamides
11/22/2001	WO2001087828A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
11/22/2001	WO2001087826A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
11/22/2001	WO2001087822A1 Novel phenyl-propargylether derivatives
11/22/2001	WO2001087816A1 Process and intermediates to prepare latanoprost
11/22/2001	WO2001087806A2 Process for the preparation of aniline compounds
11/22/2001	WO2001087477A1 Longitudinal flow reactor with a bundle of contact tubes
11/22/2001	WO2001087476A1 Counterflow reactor with a bundle of contact tubes
11/22/2001	WO2001087343A2 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
11/22/2001	US20010044468 Reduced in the body to produce a benzamidine; nontoxic
11/22/2001	DE10024348A1 Reactor having a contact tube bundle, useful for oxidation reactions, contains a throttle disk with filler particles contained within the cavity between the throttle disks.
11/22/2001	DE10024342A1 Reactor having a contact tube bundle, useful for oxidation reactions, has a heat exchange agent recycle loop fed through the chamber and rotating disks that rotate in the reactor center and edge.
11/22/2001	DE10022829A1 p-Aminophenol-Derivate und diese Verbindungen enthaltende Färbemittel p-aminophenol derivatives and compositions containing these compounds colorant
11/22/2001	DE10022828A1 New 3-furyl-, 3-thienyl- and 3-pyrrolyl-aminophenol derivatives are useful in oxidative colorants for keratin fibers, especially hair
11/22/2001	CA2410077A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	CA2409116A1 Substituted thioacetamides
11/22/2001	CA2409035A1 Hydroxamic acid derivatives
11/22/2001	CA2407469A1 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
11/22/2001	CA2375065A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
11/21/2001	EP1155011A1 Di- and tripeptide nitrile derivatives as inhibitors of cathepsin l and cathepsin s
11/21/2001	EP1155010A1 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s
11/21/2001	EP1155009A2 Protease inhibitors that overcome drug resistance
11/21/2001	EP1154983A1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
11/21/2001	EP1154981A1 Liquid crystal compounds
11/21/2001	EP1154853A1 High surface area sol-gel route prepared hydrogenation catalysts
11/21/2001	EP1044226B1 Method for coupling living cationic polymers
11/21/2001	EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/21/2001	EP0912495B1 Asymetric synthesis of chiral beta-amino acids
11/21/2001	EP0807102B1 Alkoximino acetic acid amides
11/21/2001	CN1323292A Benzoylcyclohexandiones, method for the production and use thereof as herbicides and plant growth regulators
11/21/2001	CN1323291A Diaminopropionic acid derivatives
11/21/2001	CN1322721A New agarofuran derivatives and their prepn. medicine composition and use as medicine
11/21/2001	CN1322526A Compound for treating female sexual dysfunction
11/21/2001	CN1322525A Dehydrogenated falcate micromelum costusic alcohol derivative as medicine for preventing or treating cerebral retrogressive lesion
11/21/2001	CN1075067C Furan and furan amide compound and producing process and pharmaceutical composition thereof
11/21/2001	CN1075062C 乙酸衍生物 Acetic acid derivatives
11/21/2001	CN1075061C Heterocyclylbenzonitriles
11/20/2001	US6320074 In vivo modulation of lipid metabolism, skin-related processes, autoimmune diseases, fatty acid metabolism, malignant cell development, premalignant lesions, or programmed cell death
11/20/2001	US6320061 Exchanging water for alcohol solvent to recover ascorbic acid or salt thereof from said alcohol solvent

1 ... 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 ... 472